Microglial activation is thought to be a double‐edged sword in AD, as activated microglia can phagocytose Aβ and tau and prevent proteopathy, whereas excessive inflammatory activation can accelerate plaque accumulation and synapse loss (Lananna et al., 2020). The gene discussed is MAPT; the disease is proteostasis deficiencies.